Bei Lin Selected Research

Bei Lin Research Topics

Disease

76	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 04/2003
57	Neoplasms (Cancer) 03/2024 - 04/2003
27	Ovarian Epithelial Carcinoma 01/2022 - 04/2003
20	Carcinoma (Carcinomatosis) 06/2023 - 01/2005
15	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2010
12	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 04/2005
10	Lymphatic Metastasis 01/2021 - 04/2003
4	Carcinogenesis 01/2020 - 09/2010
3	Residual Neoplasm 07/2017 - 11/2012
2	Adenocarcinoma 01/2023 - 05/2013
2	Hypoxia (Hypoxemia) 01/2022 - 09/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2012 - 11/2004
1	Carcinosarcoma 01/2023
1	Endometrioid Carcinoma 01/2023
1	Developmental Dysplasia of the Hip 11/2022
1	Papillary Thyroid Microcarcinoma 01/2022
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Cicatrix (Scar) 11/2020
1	Infections 01/2020

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2009
35	Lewis Y antigenIBA 12/2022 - 03/2008
20	Biomarkers (Surrogate Marker)IBA 06/2023 - 10/2012
13	Messenger RNA (mRNA)IBA 06/2023 - 07/2004
9	AntigensIBA 12/2022 - 01/2013
7	IntegrinsIBA 06/2015 - 07/2010
6	Annexin A2 (Annexin II)IBA 12/2021 - 11/2014
5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2018
5	OligosaccharidesIBA 06/2015 - 06/2008
4	ParaffinIBA 01/2023 - 01/2015
4	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2012
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2020
4	Carboplatin (JM8)FDA LinkGeneric 06/2015 - 07/2004
3	p38 Mitogen-Activated Protein KinasesIBA 12/2022 - 01/2022
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 11/2020
3	Transcription Factors (Transcription Factor)IBA 11/2020 - 02/2015
3	Long Noncoding RNAIBA 04/2020 - 01/2020
3	Competitive Endogenous RNAIBA 01/2020 - 01/2018
3	Small Interfering RNA (siRNA)IBA 01/2020 - 10/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 11/2004
3	CarbohydratesIBA 12/2017 - 01/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 09/2010
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 11/2020
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 01/2020
2	EnzymesIBA 01/2021 - 04/2012
2	ChromatinIBA 11/2020 - 12/2017
2	LuciferasesIBA 11/2020 - 12/2017
2	PlatinumIBA 11/2020 - 01/2015
2	Estrogens (Estrogen)FDA Link 03/2020 - 02/2015
2	Estrogen ReceptorsIBA 03/2020 - 02/2015
2	AnnexinsIBA 01/2020 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 09/2010
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2019 - 11/2010
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2017 - 12/2012
2	TransferasesIBA 09/2016 - 09/2008
2	OligonucleotidesIBA 12/2015 - 01/2015
2	Beclin-1IBA 03/2014 - 12/2012
2	Complementary DNA (cDNA)IBA 02/2013 - 11/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2012 - 07/2004
2	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2012 - 04/2012
2	GlycolipidsIBA 01/2011 - 01/2005
2	Monoclonal AntibodiesIBA 09/2010 - 03/2008
2	SurvivinIBA 07/2004 - 04/2003
1	Immunoglobulin E (IgE)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	SugarsIBA 12/2022
1	Chemotactic FactorsIBA 01/2022
1	olaparibIBA 01/2022
1	cbr-5884IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	CateninsIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2021
1	isothiocyanic acidIBA 10/2021
1	iberin (IMSP)IBA 10/2021
1	ChemokinesIBA 01/2021
1	Cladribine FDA LinkGeneric 01/2021
1	nelarabine (506U78)FDA Link 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Keratins (Keratin)IBA 01/2021
1	SaltsIBA 11/2020
1	Therapeutic UsesIBA 11/2020
1	GlycosaminoglycansIBA 01/2020
1	PlakophilinsIBA 01/2020
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2020
1	anthrax toxin (anthrax lethal factor)IBA 01/2020
1	CytokinesIBA 01/2020
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2020
1	Proteoglycans (Proteoglycan)IBA 01/2020

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 01/2023 - 07/2004
9	Therapeutics 03/2024 - 12/2012
3	Immunotherapy 06/2022 - 01/2015
1	Cytoreduction Surgical Procedures 01/2023
1	Hip Replacement Arthroplasty (Total Hip Replacement) 11/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Immunomodulation 01/2020